Capital Advisors Ltd’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $266K | Sell |
1,257
-1
| -0.1% | -$196 | 0.03% | 275 |
|
|
2026
Q1 | $247K | Buy |
1,258
+1
| +0.1% | +$194 | 0.03% | 272 |
|
|
2025
Q4 | $218K | Hold |
1,257
| – | – | 0.02% | 278 |
|
|
2025
Q3 | $240K | Sell |
1,257
-44
| -3% | -$7.81K | 0.03% | 264 |
|
|
2025
Q2 | $234K | Hold |
1,301
| – | – | 0.03% | 255 |
|
|
2025
Q1 | $220K | Sell |
1,301
-4
| -0.3% | -$657 | 0.03% | 259 |
|
|
2024
Q4 | $197K | Hold |
1,305
| – | – | 0.02% | 268 |
|
|
2024
Q3 | $203K | Hold |
1,305
| – | – | 0.03% | 266 |
|
|
2024
Q2 | $179K | Buy |
1,305
+2
| +0.2% | +$274 | 0.02% | 281 |
|
|
2024
Q1 | $173K | Buy |
1,303
+57
| +5% | +$7.4K | 0.02% | 288 |
|
|
2023
Q4 | $172K | Sell |
1,246
-24
| -2% | -$3.15K | 0.02% | 281 |
|
|
2023
Q3 | $155K | Buy |
1,270
+30
| +2% | +$4K | 0.02% | 281 |
|
|
2023
Q2 | $174K | Sell |
1,240
-1
| -0.1% | -$138 | 0.03% | 273 |
|
|
2023
Q1 | $176K | Sell |
1,241
-22
| -2% | -$3.15K | 0.03% | 249 |
|
|
2022
Q4 | $198K | Buy |
1,263
+23
| +2% | +$3.31K | 0.03% | 239 |
|
|
2022
Q3 | $152K | Sell |
1,240
-7
| -0.6% | -$922 | 0.03% | 267 |
|
|
2022
Q2 | $166K | Buy |
1,247
+3
| +0.2% | +$409 | 0.03% | 258 |
|
|
2022
Q1 | $170K | Buy |
1,244
+1
| +0.1% | +$139 | 0.03% | 257 |
|
|
2021
Q4 | $215K | Buy |
1,243
+58
| +5% | +$8.82K | 0.03% | 219 |
|
|
2021
Q3 | $172K | Hold |
1,185
| – | – | 0.03% | 234 |
|
|
2021
Q2 | $156K | Hold |
1,185
| – | – | 0.03% | 229 |
|
|
2021
Q1 | $152K | Hold |
1,185
| – | – | 0.03% | 207 |
|
|
2020
Q4 | $141K | Hold |
1,185
| – | – | 0.03% | 200 |
|
|
2020
Q3 | $136K | Hold |
1,185
| – | – | 0.03% | 196 |
|
|
2020
Q2 | $135K | Hold |
1,185
| – | – | 0.04% | 190 |
|
|
2020
Q1 | $95K | Buy |
1,185
+44
| +4% | +$4.55K | 0.03% | 203 |
|
|
2019
Q4 | $122K | Hold |
1,141
| – | – | 0.03% | 194 |
|
|
2019
Q3 | $122K | Hold |
1,141
| – | – | 0.03% | 183 |
|
|
2019
Q2 | $116K | Hold |
1,141
| – | – | 0.03% | 194 |
|
|
2019
Q1 | $103K | Hold |
1,141
| – | – | 0.03% | 212 |
|
|
2018
Q4 | $95K | Hold |
1,141
| – | – | 0.03% | 210 |
|
|
2018
Q3 | $123K | Buy |
+1,141
| New | +$125K | 0.03% | 195 |
|
Other funds holding DGX
EIG
Capital Advisors Ltd's DGX Position: Q2 2026 in Review
Capital Advisors Ltd reduced its Quest Diagnostics (DGX) stake by 0.08% in Q2 2026, selling an estimated $196 and leaving 1,257 shares worth $266K. The position accounts for 0.03% of the portfolio, ranked #275.
Capital Advisors Ltd first reported a position in DGX in Q3 2018 and has held it in 32 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Capital Advisors Ltd held 1,257 shares of Quest Diagnostics worth $266K as of Q2 2026.
- Capital Advisors Ltd sold 1 Quest Diagnostics share in Q2 2026, an estimated $196.
- Quest Diagnostics made up 0.03% of Capital Advisors Ltd's portfolio in Q2 2026, its #275 holding.
- Capital Advisors Ltd first reported a position in Quest Diagnostics in Q3 2018 and has held it in 32 quarters since.
- 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.